Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) is an Irvine, CA-based medical device company offering the smallest, longest-lived Sacral Neuromodulation System for patients suffering from Urinary and Fecal dysfunction. The Axonics r-SNM System™ is approved in Europe, Canada and Australia and undergoing a pivotal study in the US for the purposes of securing PMA approval.